In this talk Mark will explore the concept of “patient capital”, an idea which he believes must be accepted if the UK is to become home to more successful start-ups. He’ll also explain what he thinks about gazelles, 800lb gorillas, and Unicorns and how, if they really want to, entrepreneurs can truly create their own luck.
A Type 1 Diabetes diagnosis is perhaps an unusual start to a career in tech. But for 15 year old Mark Payton, as he lay in a hospital bed with his grandparents arguing over the genetic heritage of his newly detected disease, a potential career in the military fell swiftly by the wayside and research into the science of “why me” took centre stage. After a degree in Biochemistry, a PhD in the molecular Immunology of Type 1 Diabetes and working with some of Oxford University’s most acclaimed researchers, Mark was fortunate enough to be part of a team that developed a predictive test for diabetes with his research leading to a start-up business that subsequently listed on the London Stock Exchange. More recently, Mark led a management buyout to form what is now Mercia Technologies PLC to invest in and support start-up businesses.
This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at http://ted.com/tedx